This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Cramer's 'Mad Money' Recap: A Slumbering Market

Stocks in this article: AXP BIIB REGN UAL LPI AAPL DELL LULU ABT PFE AGNC CAT KELYA FE ESRX CVS PSEC

Cramer said while the old Abbott traded at 12 times earnings with a 9% growth rate, the new Abbott is trading as 17 times earnings with growth expected in the low teens. This multiple expansion, along with solid management and conservative guidance makes Abbott Labs a buy, said Cramer.

So what about Abbvie? Cramer said he was not as impressed. Abbvie does have good management and a decent portfolio of drugs, he noted, but the company's main product, Humira, goes off-patent in 2017 -- something that investors will begin to take into consideration soon.

He said this will be huge for the company as investors don't yet know if Abbvie has enough in its pipeline to make up for the coming Humira losses. At its present valuation, Cramer noted Abbvie trades for 11 times earnings, about on par with Pfizer (PFE), which has a solid track record and a known pipeline of new drugs. Cramer advised selling shares of Abbvie.

Off the Charts

In the "Off The Charts" segment, Cramer went head to head with colleague Carly Garner over the future price of natural gas.

Cramer said that, typically, natural gas sees a decline in late-January right before rallying between February through April. But with such a glut of natural gas in our country, is the seasonal cycle now broken? The number of natural gas rigs fell by 46% in 2012, but is that enough to stabilize prices?

According to Garner's research, the answer is most likely "no," as the price of natural gas has been trading in a wedge pattern since its lows in April 2009. Natural gas currently has a ceiling of $3.70 and a floor of $3.20 with both the RSI, relative strength indicator, and the WPR, or Williams percent range, pointing towards more selling to come.

Garner expects that if natural gas falls below $3.20, the commodity could see $2.60 or even $2.15 if emotions begin to trump the fundamentals.

Cramer said he agreed with the technicals that, at least in the short term, the price of natural gas could be in trouble. He said that given demand and supply levels, the February rally will likely remain intact, but investors shouldn't consider buying in quite yet ahead of that expected rally.

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs